Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mills

Showing results (381-390 of 393) with videos related to

Pageof 40
Sort By:
The Journal of Infectious Diseases|September 25, 2019
Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military PopulationMichele D Spring, Jason C Sousa, Qigui Li, et al.
BMJ Open|April 26, 2024
Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trialJonathan Mant, Rakesh N Modi, Andrew Dymond, et al.
BMJ Open|July 8, 2021
Repetitive transcranial magnetic stimulation (rTMS) in autism spectrum disorder: protocol for a multicentre randomised controlled clinical trialPeter G Enticott, Karen Barlow, Adam J Guastella, et al.
The Lancet. Infectious Diseases|June 30, 2023
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trialMichael A Koren, Leyi Lin, Kenneth H Eckels, et al.
Molecular Psychiatry|November 16, 2021
Genome-wide interaction study with major depression identifies novel variants associated with cognitive functionAnbupalam Thalamuthu, Natalie T Mills, Klaus Berger, et al.
Hypertension (Dallas, Tex. : 1979)|September 14, 2016
Research Needs to Improve Hypertension Treatment and Control in African AmericansPaul K Whelton, Paula T Einhorn, Paul Muntner, et al.
The Lancet. Infectious Diseases|July 29, 2019
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trialKayvon Modjarrad, Christine C Roberts, Kristin T Mills, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 14, 2024
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUMColleen Loo, Nick Glozier, David Barton, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trialColleen Loo, Nick Glozier, David Barton, et al.
Translational Psychiatry|May 3, 2017
Subcortical brain structure and suicidal behaviour in major depressive disorder: a meta-analysis from the ENIGMA-MDD working groupM E Rentería, L Schmaal, D P Hibar, et al.
Pageof 40

Showing results (381-390 of 393) with videos related to

Sort By:
Pageof 40
The Journal of Infectious Diseases|September 25, 2019
Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military PopulationMichele D Spring, Jason C Sousa, Qigui Li, et al.
BMJ Open|April 26, 2024
Randomised controlled trial of population screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the SAFER trialJonathan Mant, Rakesh N Modi, Andrew Dymond, et al.
BMJ Open|July 8, 2021
Repetitive transcranial magnetic stimulation (rTMS) in autism spectrum disorder: protocol for a multicentre randomised controlled clinical trialPeter G Enticott, Karen Barlow, Adam J Guastella, et al.
The Lancet. Infectious Diseases|June 30, 2023
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trialMichael A Koren, Leyi Lin, Kenneth H Eckels, et al.
Molecular Psychiatry|November 16, 2021
Genome-wide interaction study with major depression identifies novel variants associated with cognitive functionAnbupalam Thalamuthu, Natalie T Mills, Klaus Berger, et al.
Hypertension (Dallas, Tex. : 1979)|September 14, 2016
Research Needs to Improve Hypertension Treatment and Control in African AmericansPaul K Whelton, Paula T Einhorn, Paul Muntner, et al.
The Lancet. Infectious Diseases|July 29, 2019
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trialKayvon Modjarrad, Christine C Roberts, Kristin T Mills, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 14, 2024
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial - CORRIGENDUMColleen Loo, Nick Glozier, David Barton, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 18, 2023
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trialColleen Loo, Nick Glozier, David Barton, et al.
Translational Psychiatry|May 3, 2017
Subcortical brain structure and suicidal behaviour in major depressive disorder: a meta-analysis from the ENIGMA-MDD working groupM E Rentería, L Schmaal, D P Hibar, et al.
Pageof 40